Articles
-
1 week ago |
theaustralian.com.au | Lydia Lynch |Peta Credlin |Eli Greenblat |James Kirby
StockheadStockhead’s Tylah Tully unpacks the latest from Lumos Diagnostics (ASX:LDX), who have enrolled its 500th patient in a CLIA waiver study for FebriDx, its rapid point-of-care diagnostic test to differentiate between bacterial and non-bacterial acute respiratory infections. The company has a funding partnership with the US government’s Biomedical Advanced Research and Development Authority (BARDA).
-
2 weeks ago |
theaustralian.com.au | Joe Kelly |Ben Horne |Peta Credlin |damon johnston
StockheadTylah Tully chats with Belararox (ASX:BRX) managing director Arvind Misra about the company's latest drilling campaign. It's maiden campaign at the Tambo South and Malambo targets, part of the highly prospective TMT project in Argentina's San Juan Province, has proven fruitful. First pass drilling intersected multiple copper mineralised intervals, with the size of the system still unknown. Misra also shares the progress made at the company's KCB project in Botswana.
-
2 months ago |
theaustralian.com.au | Jack Quail |Noah Yim |Rhiannon Down |Peta Credlin
Perpetual Resources sampling reinforces the presence of high-grade lithium at Igrejinha Samples have also identified high-grade caesium mineralisation in historical workings Results validate belief the project is a large, high-grade system with potential well beyond initial expectations Special Report: Sampling of outcropping pegmatites at Perpetual Resources’ Igrejinha project has returned impressive spodumene grades that reinforce the presence of high-grade lithium across an increasingly...
-
2 months ago |
theaustralian.com.au | Peta Credlin |Liam Mendes |Yoni Bashan |Jack Quail
Israel is reportedly planning to snub Pope Francis’s funeral on Saturday, with no government ministers set to attend. Jerusalem is sending only its ambassador to the Vatican – the lowest level of representation possible, the Times of Israel reports. According to the Israeli embassy to the Vatican, it will be represented by ambassador Yaron Sideman. “It’s a low point in a spiral,” a diplomat told The Times of Israel.
-
2 months ago |
theaustralian.com.au | Peta Credlin |Liam Mendes |Yoni Bashan |Greg Sheridan
StockheadRegenerative medicine developer Orthocell (ASX:OCC) has appointed the first four US distributors for its flagship nerve repair product Remplir. The appointments follow FDA clearance for Remplir which landed earlier this month, and Orthocell are expecting first sales in the US very soon. Today, the US' nerve repair market is valued at US$1.6 billion. Orthocell will tap this market through distributors in Michigan, Virginia, Colorado and Indiana.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →